SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the December 2023 quarter moved down to Rs. 472.34 millions as compared to Rs. 601.40 millions during the year-ago period.The Net Profit of the company slipped to Rs. 39.63 millions from Rs. 77.85 millions, a decline of -49.09% on QoQ basis.Operating Profit reported a sharp decline to 59.17 millions from 103.75 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 472.34 601.40 -21.46 1652.16 1812.63 -8.85 2367.14 2175.84 8.79
Other Income 25.21 17.41 44.80 67.92 31.76 113.85 57.34 34.27 67.32
PBIDT 59.17 103.75 -42.97 271.90 318.90 -14.74 398.85 284.55 40.17
Interest 2.26 1.77 27.68 5.97 2.17 175.12 4.13 2.85 44.91
PBDT 56.91 101.98 -44.19 265.93 282.14 -5.75 360.13 281.70 27.84
Depreciation 4.12 3.30 24.85 12.60 7.27 73.31 12.05 15.26 -21.04
PBT 52.79 98.68 -46.50 253.33 274.87 -7.84 348.08 266.44 30.64
TAX 13.16 20.83 -36.82 64.19 63.69 0.79 80.87 77.87 3.85
Deferred Tax -0.56 10.13 -105.53 -1.37 2.77 -149.46 4.56 3.84 18.75
PAT 39.63 77.85 -49.09 189.14 211.18 -10.44 267.21 188.57 41.70
Equity 131.44 130.99 0.34 131.44 130.99 0.34 130.99 130.99 0.00
PBIDTM(%) 12.53 17.25 -27.39 16.46 17.59 -6.46 16.85 13.08 28.84

Jagsonpal Pharma Share Price

194.60 0.55 (0.28%)
17-Apr-2026 11:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1682.80
Dr. Reddys Lab 1222.80
Cipla 1237.50
Zydus Lifesciences 945.25
Lupin 2317.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×